Use of Identical INN “Imiglucerase” for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database

por Tsang, So-Fai, Pandya, Shirali, Barakov, Kristina, Keutzer, Joan, Lewis, Grace, Ross, Leorah, Freisens, Selena
Publicado 2022

Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1

por Vu, Lucie, Cox, Gerald F., Ibrahim, Jennifer, Peterschmitt, M. Judith, Ross, Leorah, Thibault, Nathan, Turpault, Sandrine
Publicado 2020

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

por Locatelli, Franco, Lang, Peter, Corbacioglu, Selim, LI, Amanda, De La Fuente, Josu, Wall, Donna, Meisel, Roland, Shah, Ami J., Liem, Robert, Mapara, Markus, Carpenter, Ben, Kwiatkowski, Janet, Domenica Cappellini, Maria, Kattamis, Antonis, Sheth, Sujit, Grupp, Stephan, Kohli, Puja, Shi, Daoyuan, Ross, Leorah, Bobruff, Yael, Simard, Christopher, Zhang, Lanju, Khanh Morrow, Phuong, Hobbs, Bill, Frangoul, Haydar
Publicado 2023